Compare Novartis AG (NVS) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Wipro Limited — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Wipro Limited trades at $1.83 (market cap $18.49B). The key difference: Novartis AG is far larger — about 15.7× Wipro Limited's market cap, and Wipro Limited pays the higher dividend (4.68%). Which is the better fit depends on your goals.
| NVS | WIT | |
|---|---|---|
Market Cap | $290.25B | $18.49B |
Sector | Health | Technology |
52-Week High | $168.62 | $3.06 |
52-Week Low | $113.50 | $1.82 |
Enterprise Value | $330.27B | $16.42B |
Dividend Yield | 3.17% | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
